“Trends and Growth Opportunities Reshaping the Future of the Biopharma Industry: 2026–2040”

2 September 2026 | 4 – 5 pm (CEST) | Webinar

The biopharmaceutical industry is entering a period of major transformation, with structural, technological, and global forces expected to shape the sector over the next 15 years. This webinar will explore four key aspects of this transformation: R&D innovation, clinical and sustainable manufacturing, commercial strategy, and regulatory dynamics. You will learn how AI, machine learning, and advanced diagnostics are reshaping drug discovery, alongside the growing adoption of personalized medicine and decentralized clinical trials. The session will also examine the shift toward more sustainable production, the transition from blockbuster drugs to diversified therapies and value-based pricing, and the growing influence of emerging markets, with China playing an increasingly important role. Finally, we will look at regulatory dynamics, including FDA/EMA alignment and its potential to streamline access to new treatments.

SPARK Europe invites you to join the webinar on 2 September at 16:00 CEST and gain insights from Anantharaman K V, Research Director for Healthcare & Life Sciences at Frost & Sullivan, who brings over 25 years of experience in the healthcare and life sciences industry.

The webinar, hosted by SPARK Tel Aviv, will be held online via Zoom - please register here.